Patients who have been prescribed single pill Caduet are eligible to participate in this
study. Patients will be treated in this study according to prevailing local clinical
practice following the locally approved product labeled recommendations.
- Known hypersensitivity to dihydropyridines, amlodipine, atorvastatin, or any component
of this medication,
- Active liver disease or unexplained persistent elevations of serum transaminases
exceeding three times the upper limit of normal,
- Or who are pregnant, breast-feeding, or of childbearing potential who are not using
adequate contraceptive measures. Amlodipine/atorvastatin should be administered to
women of childbearing age only when such patients are highly unlikely to conceive and
have been informed of the potential hazards to the fetus.